A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen
- Status
- TERMINATED
- Phase
- PHASE2
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
- Status
- COMPLETED
- Phase
- PHASE1
A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
- Status
- COMPLETED
- Phase
- N/A
Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease
- Status
- COMPLETED
- Phase
- NA
Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)
- Status
- COMPLETED
- Phase
- N/A
Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year
- Status
- COMPLETED
- Phase
- N/A
Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation
- Status
- COMPLETED
- Phase
- PHASE4
Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy
- Status
- COMPLETED
- Phase
- PHASE3
MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney Transplantation
- Status
- UNKNOWN
- Phase
- NA
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE4
Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE4
TO Compare the Triple Drug Therapy and Dual Therapy .
- Status
- UNKNOWN
- Phase
- PHASE4